Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

The complex relationship between research and health policy is illustrated by the ongoing discussion regarding the association between HIV acquisition and hormonal contraception, and in particular, progestogen-only injectable contraceptives (POIs). Despite a body of epidemiological, translational, and basic science research, the question persists as to whether there exists a causal increased risk of HIV acquisition in women who use POIs. The World Health Organization (WHO) experience with continually reviewing current research evidence and with the implementation of evidence-based guidelines reflects how challenging creating health care policy can be. Translating research into policy must account for the needs and concerns of multiple stakeholders as well as the people it ultimately will affect. This session will highlight several aspects of this experience to show how challenging this process can be. It is aimed at policy makers, ministries of health, advocates and researchers.

07:00
FRSA0801
Welcome
James Kiarie, Coordinator, Human Reproduction Team, WHO Department of Reproductive Health and Research, Switzerland
Slides
07:05
FRSA0802
Development of WHO MEC guidelines
James Kiarie, Coordinator, Human Reproduction Team, WHO Department of Reproductive Health and Research, Switzerland
Slides
07:15
FRSA0803
Differences in DMPA-IM, DMPA-SC and NET-EN relative to the potential impact on HIV acquisition in women
Renee Heffron, Departments of Global Health and Epidemiology, International Clinical Research Center, University of Washington, United States
07:25
FRSA0804
Implementation of WHO MEC recommendations
Petrus Steyn, Human Reproduction Team, WHO Department of Reproductive Health and Research, Switzerland
Slides
07:35
FRSA0806
What should the advocacy agenda for the process of guidance be?
Lillian Mworeko, International Community of women living with HIV Eastern Africa (ICWEA), Uganda
07:45
FRSA0807
Discussion